← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 29, 2022Last known activity
Jul 10, 2024
Timeline
2000s
- Jun 1, 2008
Immunophotonics, Inc.— Founded
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Recent trials (3)
- NCT06630624CollaboratorPhase 1/Phase 2Jul 10, 2024
- NCT05688280Lead sponsorPhase 1/Phase 2Nov 29, 2022
- NCT05688280Study directorPhase 1/Phase 2Nov 29, 2022
Details
- Founded
- St Louis, MO, US Jun 1, 2008
- Last known activity
- Jul 10, 2024